Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep;7(3):339-352.
doi: 10.1007/s40121-018-0205-2. Epub 2018 Jun 19.

Improvement of Hepatic and Extrahepatic Complications from Chronic Hepatitis C After Antiviral Treatment: A Retrospective Analysis of German Sickness Fund Data

Michael R Kraus  1 , Henning Kleine  2 , Stefanie Thönnes  3 , Marc Pignot  4 , Yuri Sanchez Gonzalez  5
Affiliations

Improvement of Hepatic and Extrahepatic Complications from Chronic Hepatitis C After Antiviral Treatment: A Retrospective Analysis of German Sickness Fund Data

Michael R Kraus et al. Infect Dis Ther. 2018 Sep.

Abstract

Introduction: German data regarding the economic burden of chronic hepatitis C (CHC) and potential benefits of CHC treatment are limited. To address this issue, we evaluated the role of treatment in mitigating the economic burden of hepatic and extrahepatic complications (EHCs) from CHC virus infection in Germany.

Methods: This retrospective, cross-sectional study used claims data from the Betriebskrankenkasse German sickness fund (2007-2014) to assess the medical costs of hepatic complications and EHCs, including conditions that are prevalent and behavioral factors associated with CHC. All-cause costs, medical costs related to hepatic and EHCs, and CHC-related and non-CHC-related pharmacy costs (adjusted to the 2016 euro rate) were calculated and compared between CHC patients' treated (n = 1714) and untreated time (n = 7124) and CHC patients that initiated treatment early (i.e., without cirrhosis; n = 1552) vs. late (i.e., with cirrhosis; n = 162).

Results: CHC treatment was associated with an average adjusted savings of €1885 in annual all-cause medical costs per patient, with a significant proportion attributed to EHC-related cost savings (adjusted difference, €1363; P < 0.01). Although initiating CHC treatment early was economically beneficial compared with initiating treatment late, the total cost savings were not significantly different (annual average adjusted difference, €3831; P = 0.27). However, nearly 60% of these savings were EHC related (adjusted difference, €2255; P < 0.01).

Conclusion: CHC is associated with a significant economic burden in Germany, largely due to EHCs. Antiviral treatment may reduce the burden of CHC and result in significant cost savings, even when initiated at earlier stages of liver disease.

Funding: AbbVie Inc.

Keywords: Cirrhosis; Costs; Early treatment; Extrahepatic manifestations; Fibrosis; Hepatitis C virus; Liver disease.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. World Health Organization. Hepatitis C in the WHO European Region. 2017 July. http://www.euro.who.int/__data/assets/pdf_file/0010/283357/fact-sheet-en.... Accessed Sept 13, 2017.
    1. Gower E, Estes C, Blach S, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61:S45–S57. doi: 10.1016/j.jhep.2014.07.027. - DOI - PubMed
    1. Poethko-Muller C, Zimmermann R, Hamouda O, et al. Epidemiology of hepatitis A, B, and C among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1) Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:707–715. doi: 10.1007/s00103-013-1673-x. - DOI - PubMed
    1. Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, Calinas F, et al. The present and future disease burden of hepatitis C virus (HCV) infection with today’s treatment paradigm. J Viral Hepat. 2014;21(Suppl 1):34–59. doi: 10.1111/jvh.12248. - DOI - PubMed
    1. Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. World Health Organization; 2016. ISBN 978 92 4 154961 5. - PubMed

LinkOut - more resources